English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [698]
News [2425]
Articles [196]
Editorials [6]
Conferences [89]
elearning [31]
Exploring colorectal cancer in Hispanic/Latino populations through multi-omics...
Dr Enrique Velazquez Villarreal - CIty of Hope, Duarte, USA
Exploring colorectal cancer in Hispanic/Latino populations through multi-omics analysis of MYC gene and WNT signalling pathway alteration ( Dr Enrique Velazquez Villarreal - CIty of Hope, Duarte, USA )
7 May 2025
Higher visceral fat linked to reduced overall survival in older adults with...
Dr Supriya Maheshwari - University of Alabama, Tuscaloosa, USA
Higher visceral fat linked to reduced overall survival in older adults with newly diagnosed gastrointestinal malignancies ( Dr Supriya Maheshwari - University of Alabama, Tuscaloosa, USA )
10 Mar 2025
ctDNA evaluation may play a prognostic role in stage III colon cancer treated...
Dr Jonathan Andrew Nowak - Dana-Farber Cancer Institute, Boston, USA
ctDNA evaluation may play a prognostic role in stage III colon cancer treated with celecoxib ( Dr Jonathan Andrew Nowak - Dana-Farber Cancer Institute, Boston, USA )
26 Feb 2025
Addition of trastuzumab to chemo does not provide significant survival benefit...
Dr Anna Dorothea Wagner - Lausanne University Hospital, Lausanne, Switzerland
Addition of trastuzumab to chemo does not provide significant survival benefit in HER-2 positive stomach cancer ( Dr Anna Dorothea Wagner - Lausanne University Hospital, Lausanne, Switzerland )
21 Feb 2025
SIOG 2024: Updates in radiation oncology
Dr Lucinda Morris - Crown Princess Mary Cancer Centre, Westmead, Australia
SIOG 2024: Updates in radiation oncology ( Dr Lucinda Morris - Crown Princess Mary Cancer Centre, Westmead, Australia )
19 Feb 2025
SIOG 2024: Updates in medical oncology
Dr Capucine Baldini - Gustave Roussy, Villejuif, France
SIOG 2024: Updates in medical oncology ( Dr Capucine Baldini - Gustave Roussy, Villejuif, France )
19 Feb 2025
Low-dose aspirin can reduce recurrence rates in colorectal cancer patients with...
Prof Anna Martling - Karolinska Institutet, Stockholm, Sweden
Low-dose aspirin can reduce recurrence rates in colorectal cancer patients with PI3K pathway alterations ( Prof Anna Martling - Karolinska Institutet, Stockholm, Sweden )
14 Feb 2025
Nivolumab plus ipilimumab shows superior efficacy in metastatic colorectal...
Dr Thierry Andre - Sorbonne Université and Saint Antoine Hospital, Paris, France
Nivolumab plus ipilimumab shows superior efficacy in metastatic colorectal compared to nivolumab monotherapy ( Dr Thierry Andre - Sorbonne Université and Saint Antoine Hospital, Paris, France )
13 Feb 2025
Assessment and management of toxic effects of cancer therapy in elderly...
Dr Houda Belfekih - Mohamed Taher Maamouri Hospital, Nabeul, Tunisia
Assessment and management of toxic effects of cancer therapy in elderly patients in Tunisia ( Dr Houda Belfekih - Mohamed Taher Maamouri Hospital, Nabeul, Tunisia )
13 Feb 2025
Robotic surgery for older patients with colorectal cancer shows positive...
Prof Lore Decoster - University Hospital Brussels, Brussels, Belgium
Robotic surgery for older patients with colorectal cancer shows positive outcomes ( Prof Lore Decoster - University Hospital Brussels, Brussels, Belgium )
13 Feb 2025
Blood-based test may provide a convenient and effective option for CRC...
Dr Aasma Shaukat - NYU Grossman School of Medicine, New York, USA
Blood-based test may provide a convenient and effective option for CRC screening in the average-risk U.S. population ( Dr Aasma Shaukat - NYU Grossman School of Medicine, New York, USA )
29 Jan 2025
Everolimus plus lanreotide might be a new standard treatment in the first-line...
Dr Susumu Hijioka - National Cancer Center Hospital, Chuo City, Japan
Everolimus plus lanreotide might be a new standard treatment in the first-line setting for grade 1/2 GEP-NETs ( Dr Susumu Hijioka - National Cancer Center Hospital, Chuo City, Japan )
29 Jan 2025
<12345...59>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top